Table 1:
Baseline characteristics and presenting symptoms among 59 patients undergoing surgical treatment of SFTP from 1977 to 2010
| Characteristic | Result |
|---|---|
| Age | |
| Median (range) | 60 (28–79) |
| Mean ± SD | 57.1 ± 13.6 |
| Sex, n (%) | |
| Male | 32 (54) |
| Female | 27 (46) |
| Toxic exposures, n (%) | |
| Tobacco | 25 (42) |
| Pack-year, mean ± SD | 39.8 ± 28.4 |
| Asbestos | 5 (8) |
| Comorbidities, n (%) | |
| Hypertension | 16 (27) |
| Coronary artery disease | 3 (5) |
| Diabetes | 2 (3) |
| Chronic obstructive pulmonary disease | 2 (3) |
| Asthma | 2 (3) |
| Atrial fibrillation | 1 (2) |
| History of neoplasia, n (%) | 10 (17) |
| Schwannoma | 3 (5) |
| Breast | 2 (3) |
| Lung | 1 (2) |
| Thyroid | 1 (2) |
| Melanoma | 1 (2) |
| Endometrium | 1 (2) |
| Prostate | 1 (2) |
| Previous surgery, n (%) | 20 (34) |
| Ongoing pregnancy, n (%) | 1 (4) |
| Presence of symptoms, n (%) | 32 (54) |
| Duration of symptoms (months) | |
| Median (range) | 4.5 (0.25–60) |
| Symptoms, n (%) | |
| Chest pain | 13 (22) |
| Cough | 11 (19) |
| Dyspnoea | 10 (17) |
| Flu-like | 6 (10) |
| Weight loss | 4 (7) |
| Abdominal pain | 1 (2) |
| Paraneoplastic syndromes, n (%) | |
| Hypertrophic osteoarthropathy | 2 (3) |
| Hypoglycaemia | 1 (2) |